# Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of Age

> **NCT05590884** · PHASE2 · COMPLETED · sponsor: **Guerbet** · enrollment: 36 (actual)

## Conditions studied

- Central Nervous System Diseases
- Pediatric Disorder
- Body Indication

## Interventions

- **DRUG:** Gadopiclenol

## Key facts

- **NCT ID:** NCT05590884
- **Lead sponsor:** Guerbet
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-21
- **Primary completion:** 2024-09-30
- **Final completion:** 2024-09-30
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2025-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05590884

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05590884, "Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of Age". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05590884. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*